Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000905718-18-000020

Director sold 37,754 shares at $26.76 ($1,010,123)

From the SEC's structured data for this filing

Trades in this filing

EMSTER KURT VON · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2018-01-02 Sale : show line 1 in the form −37,754 $26.76 $1,010,123 1,913,605 I
Open-market sales · 37,754 sh · avg $26.76 · $1,010,123
Loading xslF345X03/crisprfm4_jan22018.xml…